18010362_Welcome-HCD-economics_v2-01.jpg

Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group

Prime Global 24 January, 2022

Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies, including market access consultancy, Prime Access, and patient engagement experts, Prime Patient, to deliver integrated evidence-led services.

read more >>
, , , , , , , , , ,
Prime GlobalPrime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group
18010362_digital_payerv3-01.png

The Digital Payer: Fact or Fiction?

Prime Global 21 October, 2021

Our experts, Sue O’Leary, Senior Vice President Prime Access, Jenny Blackham, Vice President Client Partnerships and Head of Digital Solutions Michelle Collins recently led a webinar with the team at NetworkPharma and MedComms Networking. Discussing ‘the digital payer – fact or fiction?’ the webinar was a brilliant platform to discuss perspectives and share ideas about about evolving payer communications in the changing digital landscape.

read more >>
, , , , , , ,
Prime GlobalThe Digital Payer: Fact or Fiction?
18010359-Omics-future-of-PM-social-v7a_FacebookLinkedInTwitter.png

Overcoming the challenges of gene therapy

Prime Global 15 September, 2021

Once considered science fiction, a number of different gene therapy approaches are now being adopted in clinical practice to target a range of diseases. Our Prime Omics team discuss ‘overcoming the challenges of gene therapy’ in their whitepaper. Read the full piece below.
read more >>

, , , , , ,
Prime GlobalOvercoming the challenges of gene therapy
18010362_Evidence_or_Opinion_TL_v1-002_Page_2.png

Evidence or Opinion: what is really driving decisions following accelerated approvals?

Prime Global 3 September, 2021

Delivery of confirmatory studies following any accelerated approval has been an area of growth and contention. Sue O’Leary, Senior Vice President of Prime Access, and Jenny Blackham, Vice President of Client Partnerships, take a closer look at what is happening.

read more >>
, , , , ,
Prime GlobalEvidence or Opinion: what is really driving decisions following accelerated approvals?